Cet événement s’adresse aux cliniciens, aux chercheurs et aux professionnels de la santé. Veuillez noter que cet événement se déroule en anglais.
Sujet
Management of tricuspid valve regurgitation: Why, When, Who and How to treat?
Dr. Messika-Zeitoun is an outstanding clinician-investigator renown for his novel insights into the pathophysiology and management of Valvular Heart Disease (VHD), which is transforming the landscape of valvular heart disease care locally, nationally, and internationally. Read more about his research success.
This presentation will be held in-person only. Light refreshments will be provided.
Conférencier
David Messika-Zeitoun, MD, PhD
Director, Centre for Valvular Heart Disease
Chair, Valve Team
University of Ottawa Heart Institute
Professor
Faculty of Medicine
University of Ottawa
Endroit
Auditorium Foustanellas Centre (H-2367).
Coût
Gratuit.
Inscription
Non requise.